Skip to main content

Retail Clinics

  • Beacon Community program seeks to curb diabetes across country

    WASHINGTON Vice President Joe Biden and the Department of Health and Human Services secretary Kathleen Sebelius have announced a pilot program designed to curb diabetes in 15 selected U.S. cities with the help of health-information technology.

  • Sandoz first to receive FDA approval for Lovenox generic

    SILVER SPRING, Md. The Food and Drug Administration has approved the first generic version of a Sanofi-Aventis injected drug used to treat deep vein thrombosis, the agency said Friday.

     

    The FDA approved generic enoxaparin sodium, a version of Sanofi’s Lovenox, developed under a collaboration between Momenta Pharmaceuticals and Sandoz, the generics division of Swiss drug maker Novartis.

     

     

  • Study: Two therapies may slow diabetic retinopathy in Type 2 diabetes

    WINSTON-SALEM, N.C. In high-risk adults with Type 2 diabetes, researchers have found that two therapies may slow the progression of diabetic retinopathy, an eye disease that is the leading cause of vision loss in working-age Americans.

  • NACDS urges FDA to move carefully in risk management rules for opioids

    ROCKVILLE, Md. Note to the Food and Drug Administration from the chain pharmacy industry: when it comes to beefing up oversight and regulation of some high-risk medications, slow and steady is the best approach.

  • Pharmacist-patient relationships improve health, lower costs of care, UNC-Kerr study reveals

    RALEIGH, N.C. A healthy relationship with a community pharmacist can improve health outcomes for patients and save money, a new collaborative study from North Carolina-based Kerr Drug and the University of North Carolina revealed.

    Those benefits stem from direct interventions in patient therapy by pharmacists, coupled with a coordinated approach to the patient’s treatment regimen by his or her pharmacist and doctor, according to Kerr.

  • Nestle teams up with Cleveland Clinic for collaborative study

    GLENDALE, Calif. Nestle announced Thursday its donation to Cleveland Clinic's Lerner Research Institute to fund a collaborative study focused on examining the effects of a diet rich in whole grains on body composition and energy metabolism.

  • Reaching out to new CMS administrator Berwick, NACDS highlights pro-patient, pro-pharmacy goals

    ALEXANDRIA, Va. The National Association of Chain Drug Stores is moving quickly to establish a working relationship with newly installed Medicare and Medicaid chief Donald Berwick.

    NACDS on Wednesday sent a letter to Berwick, who was tapped by President Obama to serve as the new administrator of the Centers for Medicare & Medicaid Services. NACDS president and CEO Steve Anderson urged continued collaboration with CMS on issues related to pharmacy that he said are vital to quality health care and cost reduction.

  • FDA approves additional strengths of Actavis' generic Wellbutrin SR

    MORRISTOWN, N.J. Actavis has received regulatory approval from the Food and Drug Administration for a generic antidepressant, the drug maker announced Wednesday.

    Actavis said it immediately will begin distributing its bupropion HCl extended-release (SR) tablets in 100-mg and 200-mg strengths. The drug is the generic equivalent of GlaxoSmithKline's Wellbutrin SR. Actavis already has marketed generic Wellbutrin SR in the 150-mg strength. The drug maker received approval in March 2008.

X
This ad will auto-close in 10 seconds